Comparison of the Anti-bronchoconstrictor Activities of Inhaled Formoterol, its (R,R)- and (S,S)-Enantiomers and Salmeterol in the Rhesus Monkey

By Fozard J.R.   Buescher H.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 4, 2001-08 ,pp. : 289-295

Academic Press

Access to resources Recommend Favorite

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD

By Cazzola M.   Marco F.D.   Santus P.   Boveri B.   Verga M.   Matera M.G.   Centanni S.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cumulative Single Doses of Inhaled Salbutamol Enantiomers in Asthmatic Subjects

By Gumbhir-Shah K.   Kellerman D.J.   deGraw S.   Koch P.   Jusko W.J.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 6, 1999-12 ,pp. : 353-362

Academic Press

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

By Johansson Gunnar  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 695-708

Adis International

Access to resources Recommend Favorite

A comparison of salmeterol and formoterol in attenuating airway responses to short-acting 2 -agonists

By van Veen A.   Weller F.R.   Wierenga E.A.   Jansen H.M.   Jonkers R.E.  

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite